Reposition of the anti-inflammatory drug diacerein in an in-vivo colorectal cancer model

Excessive interleukin (IL)-6 production is a driver for malignancy and drug resistance in colorectal cancer (CRC). Our study investigated a seven-week post-treatment with the anti-inflammatory drug, Diacerein (Diac), alone or in combination with 5-fluorouracil (5-FU), using a 1,2-dimethylhydrazine (...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Latif, Raghda T., Wadie, Walaa, Abdel-mottaleb, Yousra, Abdallah, Dalaal M., El-Maraghy, Nabila N., El-Abhar, Hanan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802128/
https://www.ncbi.nlm.nih.gov/pubmed/35145347
http://dx.doi.org/10.1016/j.jsps.2021.12.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802128/
https://www.ncbi.nlm.nih.gov/pubmed/35145347
http://dx.doi.org/10.1016/j.jsps.2021.12.009

Ejemplares similares